Chico, California, United States The company was established in North America in United States. The main office of represented VC is situated in the Chico.
Considering the real fund results, this VC is 13 percentage points more often commits exit comparing to other organizations. The fund is generally included in less than 2 deals every year. The important activity for fund was in 2014. The higher amount of exits for fund were in 2018. Deals in the range of 10 - 50 millions dollars are the general things for fund. Opposing the other organizations, this Satter Investment Management works on 4 percentage points more the average amount of lead investments.
The current fund was established by Muneer A. Satter.
The fund has exact preference in some founders of portfolio startups. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Annexon Biosciences, Aerpio Pharmaceuticals, Akebia Therapeutics. Among the most popular fund investment industries, there are Life Science, Health Care.
The typical case for the fund is to invest in rounds with 5-6 participants. Despite the Satter Investment Management, startups are often financed by Venture Investors, Novartis Venture Fund, Triathlon Medical Venture Partners. The meaningful sponsors for the fund in investment in the same round are Novartis Venture Fund, Venture Investors, Triathlon Medical Venture Partners. In the next rounds fund is usually obtained by Novartis Venture Fund, New Enterprise Associates, Athenian Venture Partners.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Benefit Street Partners | New York, New York, United States |
| Boundary Capital Partners LLP | England, London, United Kingdom |
| Canada media fund | Canada, Ontario, Toronto |
| Cherub Fund | Kentucky, Lexington, United States |
| China Merchants Group | China, Hong Kong, Hong Kong Island |
| CoCoon Ignite Ventures | China, Hong Kong, Hong Kong Island |
| Denso | Aichi Prefecture, Japan, Kariya |
| Hudson Capital Group | Florida, Fort Lauderdale, United States |
| Interfase Capital Partners | Austin, Texas, United States |
| Intuitive Investments Group | England, London, United Kingdom |
| Jaws Ventures | Florida, Miami, United States |
| Kuanhua Investment Group | China, Hangzhou, Zhejiang |
| Logo Ventures | Istanbul, Istanbul, Turkey |
| Moji Fengyun (Beijing) Software Technology Development Co. | Beijing, Beijing, China |
| Rostra Capital | - |
| Sinolink Securities | Chengdu, China, Sichuan |
| UC Investments | - |
| University of Toronto | Canada, Ontario, Toronto |
| Ventry Industries | - |
| Wuhan Mutual Entertainment Cultural Industry Investment Management | China, Hubei, Wuhan |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Annexon Biosciences | $100M | 01 Jul 2020 | South San Francisco, California, United States | ||
Annexon Biosciences | $75M | 19 Dec 2018 | South San Francisco, California, United States | ||
Annexon Biosciences | $44M | 23 Jun 2016 | South San Francisco, California, United States | ||
Annexon Biosciences | $34M | 15 Dec 2014 | South San Francisco, California, United States | ||
Aerpio Pharmaceuticals | $22M | 23 Apr 2014 | Cincinnati, Ohio, United States | ||
Aerpio Pharmaceuticals | $36M | 06 Nov 2013 | Cincinnati, Ohio, United States | ||
Akebia Therapeutics | $41M | 04 Jun 2013 | Cambridge, Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Annexon Biosciences | $100M | 01 Jul 2020 | South San Francisco, California, United States | ||
Annexon Biosciences | $75M | 19 Dec 2018 | South San Francisco, California, United States | ||
Annexon Biosciences | $44M | 23 Jun 2016 | South San Francisco, California, United States | ||
Annexon Biosciences | $34M | 15 Dec 2014 | South San Francisco, California, United States | ||
Aerpio Pharmaceuticals | $22M | 23 Apr 2014 | Cincinnati, Ohio, United States | ||
Aerpio Pharmaceuticals | $36M | 06 Nov 2013 | Cincinnati, Ohio, United States | ||
Akebia Therapeutics | $41M | 04 Jun 2013 | Cambridge, Massachusetts, United States |
